telehealth glp-1 crackdown news today The FDA is cracking down on ‘misleading’ compounded GLP-1s from companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, Hims to stop offering GLP-1

In addition to reductions in body weight, abdominal fat and liver fat, retatrutide treatment was associated with improvements in insulin sensitivity, lipid metabolism and adipocyte hormones

TRICARE Prime and Select users retain this coverage with prior authorization, and all beneficiaries still receive GLP-1 coverage when the drug is prescribed for Type 2 diabetes

Contact your GP or NHS 111 if you experience: persistent vomiting that prevents you from keeping down fluids, signs of dehydration (dark urine, dizziness, extreme thirst), severe or bloody diarrhoea, or other concerning symptoms

So, after about a year of not seeing weight loss, her physician recommended that she go on a GLP-1, and she began taking Monjaro

Santana added that he is happy the FDA advisory committee is meeting to discuss peptides

On the other hand, tirzepatide for long-term weight loss has shown similar success